Browsing byAuthorRaven, LM
Showing results 1 to 5 of 5
| Issue Date | Title | Author(s) |
| 2022-12-20 | Diabetes medication following heart transplantation: a focus on novel cardioprotective therapies-a joint review from endocrinologists and cardiologists. | Raven, LM; Muir, CA; Macdonald, PS; Hayward, CS; Jabbour, A; Greenfield, JR |
| 2024-05 | Fournier’s gangrene in recent transplant recipient on empagliflozin | Raven, LM; Cao, JY; Macdonald, PS; Jabbour, A; Greenfield, JR |
| 2023-09 | Metabolic Sequelae of Everolimus Treatment After Cardiac Transplant: A Hypothesis-Generating Study. | Raven, LM; Muir, CA; Pouliopoulos, J; Hayward, CS; Macdonald, PS; Greenfield, JR; Jabbour, A |
| 2023-11-15 | Safety and tolerability of sodium-glucose cotransporter-2 inhibitors in bridge-to-transplant patients supported with centrifugal-flow left ventricular assist devices. | Chavali, S; Barua, S; Adji, A; Robson, D; Raven, LM; Greenfield, JR; Eckford, H; Macdonald, PS; Hayward, CS; Muthiah, K |
| 2023-03-29 | Sodium glucose co-transporter 2 inhibition with empagliflozin on metabolic, cardiac and renal outcomes in recent cardiac transplant recipients (EMPA-HTx): protocol for a randomised controlled trial. | Raven, LM; Muir, CA; Kessler Iglesias, C; Bart, NK; Muthiah, K; Kotlyar, E; Macdonald, P; Hayward, CS; Jabbour, A; Greenfield, JR |
